Carman Alenson - 21 Jun 2021 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Principal Accounting Officer
Signature
/s/ William Cook as attorney-in-fact for Carman Alenson
Issuer symbol
AGIO
Transactions as of
21 Jun 2021
Net transactions value
-$17,948
Form type
4
Filing time
23 Jun 2021, 17:28:44 UTC
Next filing
19 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Options Exercise $91,533 +1,777 $51.51 1,777 21 Jun 2021 Direct F1
transaction AGIO Common stock Sale $109,481 -1,777 -100% $61.61 0 21 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Stock option (right to buy) Options Exercise $0 -1,777 -33% $0.000000 3,555 21 Jun 2021 Common stock 1,777 $51.51 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3 This option was granted on February 14, 2020. The shares underlying this option vest as to 25% of the underlying shares on February 14, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.